Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 380 participants.
Also called NCT03773822
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 380 participants
- Sponsor
- CMC Ambroise Paré
- Registry
-
NCT03773822
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT03773822. Randomized; double masking; primary purpose treatment. Start 2019-04-19 (actual); primary completion 2023-04-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.
- Acronym
- COCCA
- Condition
- Cardiogenic Shock
- Intervention (Combination product)
- Hydrocortisone + Flucortac
- Intervention (Other)
- Placebo
- Lead sponsor
- CMC Ambroise Paré
Record details
- Record id
cardio:ct-nct03773822- Content hash
9b49004194fb4f6adf6e8c2802f8382acdaa08280b12344dc8ee9576d283fc06